![Conversion from immediate-release to extended-release lamotrigine improves seizure control | Semantic Scholar Conversion from immediate-release to extended-release lamotrigine improves seizure control | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9ced5b710afc47d0ebb57cf824e284756819a712/3-Figure1-1.png)
Conversion from immediate-release to extended-release lamotrigine improves seizure control | Semantic Scholar
![Carbamazepine Tablets, USP, 100 mg, 200 mg, 300 mg, 400 mg and Carbamazepine Tablets, USP (Chewable), 100 mg Carbamazepine Tablets, USP, 100 mg, 200 mg, 300 mg, 400 mg and Carbamazepine Tablets, USP (Chewable), 100 mg](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=1859fbe5-4110-4511-bfd2-63c190886c6f-06.jpg&id=457351)
Carbamazepine Tablets, USP, 100 mg, 200 mg, 300 mg, 400 mg and Carbamazepine Tablets, USP (Chewable), 100 mg
![PDF) Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy | Andreas Schreiner - Academia.edu PDF) Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy | Andreas Schreiner - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/47595494/mini_magick20190206-2680-1b08mmp.png?1549468664)
PDF) Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy | Andreas Schreiner - Academia.edu
![A Clinician's Guide to Oral Extended-Release Drug Delivery Systems in Epilepsy. - Abstract - Europe PMC A Clinician's Guide to Oral Extended-Release Drug Delivery Systems in Epilepsy. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6117810/bin/i1551-6776-23-4-277-f01.jpg)
A Clinician's Guide to Oral Extended-Release Drug Delivery Systems in Epilepsy. - Abstract - Europe PMC
![Extended‐release antiepileptic drugs: A comparison of pharmacokinetic parameters relative to original immediate‐release formulations - Leppik - 2013 - Epilepsia - Wiley Online Library Extended‐release antiepileptic drugs: A comparison of pharmacokinetic parameters relative to original immediate‐release formulations - Leppik - 2013 - Epilepsia - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/787575a0-7eb6-407b-94f6-8ee3f5fab422/epi12043_f1.gif)
Extended‐release antiepileptic drugs: A comparison of pharmacokinetic parameters relative to original immediate‐release formulations - Leppik - 2013 - Epilepsia - Wiley Online Library
![Lamotrigine XR Conversion to Monotherapy: First Study Using a Historical Control Group | SpringerLink Lamotrigine XR Conversion to Monotherapy: First Study Using a Historical Control Group | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13311-011-0088-3/MediaObjects/13311_2011_88_Fig3_HTML.gif)
Lamotrigine XR Conversion to Monotherapy: First Study Using a Historical Control Group | SpringerLink
![A Clinician's Guide to Oral Extended-Release Drug Delivery Systems in Epilepsy. - Abstract - Europe PMC A Clinician's Guide to Oral Extended-Release Drug Delivery Systems in Epilepsy. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6117810/bin/i1551-6776-23-4-277-t102.jpg)
A Clinician's Guide to Oral Extended-Release Drug Delivery Systems in Epilepsy. - Abstract - Europe PMC
![Steady‐state Pharmacokinetics of Lamotrigine when Converting from a Twice‐daily Immediate‐release to a Once‐daily Extended‐release Formulation in Subjects with Epilepsy (The COMPASS Study) - Tompson - 2008 - Epilepsia - Wiley Online Library Steady‐state Pharmacokinetics of Lamotrigine when Converting from a Twice‐daily Immediate‐release to a Once‐daily Extended‐release Formulation in Subjects with Epilepsy (The COMPASS Study) - Tompson - 2008 - Epilepsia - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/71647b73-9c14-425a-90cf-d6e60152525b/epi_1274_f1a.gif)
Steady‐state Pharmacokinetics of Lamotrigine when Converting from a Twice‐daily Immediate‐release to a Once‐daily Extended‐release Formulation in Subjects with Epilepsy (The COMPASS Study) - Tompson - 2008 - Epilepsia - Wiley Online Library
![A randomized, double-blind, double-dummy, multicenter trial comparing the efficacy and safety of extended- and immediate-release levetiracetam in people with partial epilepsy - Seizure - European Journal of Epilepsy A randomized, double-blind, double-dummy, multicenter trial comparing the efficacy and safety of extended- and immediate-release levetiracetam in people with partial epilepsy - Seizure - European Journal of Epilepsy](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/462c2b21-fce1-4c57-a80a-f67075251d9f/gr1_lrg.jpg)
A randomized, double-blind, double-dummy, multicenter trial comparing the efficacy and safety of extended- and immediate-release levetiracetam in people with partial epilepsy - Seizure - European Journal of Epilepsy
![A Clinician's Guide to Oral Extended-Release Drug Delivery Systems in Epilepsy. - Abstract - Europe PMC A Clinician's Guide to Oral Extended-Release Drug Delivery Systems in Epilepsy. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6117810/bin/i1551-6776-23-4-277-t101.jpg)
A Clinician's Guide to Oral Extended-Release Drug Delivery Systems in Epilepsy. - Abstract - Europe PMC
![Lamictal XR (Lamotrigine Extended-Release Tablets): Uses, Dosage, Side Effects, Interactions, Warning Lamictal XR (Lamotrigine Extended-Release Tablets): Uses, Dosage, Side Effects, Interactions, Warning](https://images.rxlist.com/images/rxlist/lamictal-xr4.gif)
Lamictal XR (Lamotrigine Extended-Release Tablets): Uses, Dosage, Side Effects, Interactions, Warning
![Use of extended-release and immediate-release anti-seizure medications with a long half-life to improve adherence in epilepsy: A guide for clinicians - Epilepsy & Behavior Use of extended-release and immediate-release anti-seizure medications with a long half-life to improve adherence in epilepsy: A guide for clinicians - Epilepsy & Behavior](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/7c767d66-8338-495d-8ba9-a5d8cc16ece9/gr1.jpg)
Use of extended-release and immediate-release anti-seizure medications with a long half-life to improve adherence in epilepsy: A guide for clinicians - Epilepsy & Behavior
![PDF) Conversion from delayed-release sodium valproate to extended-release sodium valproate: Initial results and long-term follow-up PDF) Conversion from delayed-release sodium valproate to extended-release sodium valproate: Initial results and long-term follow-up](https://i1.rgstatic.net/publication/7101859_Conversion_from_delayed-release_sodium_valproate_to_extended-release_sodium_valproate_Initial_results_and_long-term_follow-up/links/5f4e68d2299bf13a3193d361/largepreview.png)
PDF) Conversion from delayed-release sodium valproate to extended-release sodium valproate: Initial results and long-term follow-up
![Levetiracetam extended release and levetiracetam immediate release as adjunctive treatment for partial-onset seizures: An indirect comparison of treatment-emergent adverse events using meta-analytic techniques - Epilepsy & Behavior Levetiracetam extended release and levetiracetam immediate release as adjunctive treatment for partial-onset seizures: An indirect comparison of treatment-emergent adverse events using meta-analytic techniques - Epilepsy & Behavior](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b72a12f7-eb25-4f95-a26c-bee1bbf39381/gr1.jpg)